TRAIL anticorps
Aperçu rapide pour TRAIL anticorps (ABIN126992)
Antigène
Voir toutes TRAIL (TNFSF10) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- The antibody detects a 32 kDa protein, corresponding to the apparent molecular weight of TRAIL on SDS-PAGE immunoblots, in human cell lines.
-
Purification
- Affinity purified
-
-
-
-
Indications d'application
-
Western Blot: 0.5-1 μg/mL. ELISA: 2-3 μg/mL. Neutralization: 5-10 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS, pH 7.2, containing 50 % glycerol, 1 % BSA, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- TRAIL (TNFSF10) (Tumor Necrosis Factor (Ligand) Superfamily, Member 10 (TNFSF10))
-
Autre désignation
- CD253 / TRAIL
-
Sujet
- TRAIL (TNF-related apoptosis-inducing ligand), a member of the TNF ligand family, is a type II membrane protein and expressed in a variety of human tissues. Two death domains containing receptors DR4 and DR5 have been identified as the receptors for TRAIL and two decoy receptors designated DcR1 and DcR2 inhibit TRAIL function. The multiple receptors suggest a complex role for regulation of signaling by the cytokine. TRAIL induces apoptosis and NF-kB activation in many tissues and cells.Synonyms: APO2L, Apo-2 ligand, Apo-2L, TNF-related apoptosis-inducing ligand, TNFSF10, Tumor necrosis factor ligand superfamily member 10
-
ID gène
- 8743
-
NCBI Accession
- NP_003801
-
UniProt
- P50591
-
Pathways
- Apoptose, Positive Regulation of Endopeptidase Activity
Antigène
-